114 related articles for article (PubMed ID: 8749837)
21. Comparative effects of mirtazapine and fluoxetine on sleep physiology measures in patients with major depression and insomnia.
Winokur A; DeMartinis NA; McNally DP; Gary EM; Cormier JL; Gary KA
J Clin Psychiatry; 2003 Oct; 64(10):1224-9. PubMed ID: 14658972
[TBL] [Abstract][Full Text] [Related]
22. Compliance in depressed patients treated with fluoxetine or amitriptyline. Belgian Compliance Study Group.
Demyttenaere K; Van Ganse E; Gregoire J; Gaens E; Mesters P
Int Clin Psychopharmacol; 1998 Jan; 13(1):11-7. PubMed ID: 9988362
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients.
Versiani M; Moreno R; Ramakers-van Moorsel CJ; Schutte AJ;
CNS Drugs; 2005; 19(2):137-46. PubMed ID: 15697327
[TBL] [Abstract][Full Text] [Related]
24. Plasma free 3-methoxy-4-hydroxyphenylglycol predicts response to fluoxetine.
Ko HC; Lu RB; Shiah IS; Hwang CC
Biol Psychiatry; 1997 Apr; 41(7):774-81. PubMed ID: 9084896
[TBL] [Abstract][Full Text] [Related]
25. The effect of fluoxetine on anxiety and depression symptoms in cancer patients.
Razavi D; Allilaire JF; Smith M; Salimpour A; Verra M; Desclaux B; Saltel P; Piollet I; Gauvain-Piquard A; Trichard C; Cordier B; Fresco R; Guillibert E; Sechter D; Orth JP; Bouhassira M; Mesters P; Blin P
Acta Psychiatr Scand; 1996 Sep; 94(3):205-10. PubMed ID: 8891089
[TBL] [Abstract][Full Text] [Related]
26. Antidepressant response follows an exponential decay curve: replication and extension.
Boyer W
J Clin Psychopharmacol; 1997 Oct; 17(5):426-7. PubMed ID: 9315997
[No Abstract] [Full Text] [Related]
27. Effects of fluoxetine and dothiepin on 24-hour activity in depressed patients.
Stanley N; Fairweather DB; Hindmarch I
Neuropsychobiology; 1999; 39(1):44-8. PubMed ID: 9892859
[TBL] [Abstract][Full Text] [Related]
28. Placebo-controlled trial of lithium augmentation of fluoxetine and lofepramine.
Katona CL; Abou-Saleh MT; Harrison DA; Nairac BA; Edwards DR; Lock T; Burns RA; Robertson MM
Br J Psychiatry; 1995 Jan; 166(1):80-6. PubMed ID: 7894881
[TBL] [Abstract][Full Text] [Related]
29. Tricyclic antidepressants in adolescent depression. A case report.
Evans CL; Ha Y; Saisch S; Ellison Z; Fombonne E
Eur Child Adolesc Psychiatry; 1998 Sep; 7(3):166-71. PubMed ID: 9826304
[TBL] [Abstract][Full Text] [Related]
30. Fluoxetine in tricyclic refractory major depressive disorder.
Beasley CM; Sayler ME; Cunningham GE; Weiss AM; Masica DN
J Affect Disord; 1990 Nov; 20(3):193-200. PubMed ID: 2148340
[TBL] [Abstract][Full Text] [Related]
31. Are neurovegetative symptoms stable in relapsing or recurrent atypical depressive episodes?
Nierenberg AA; Pava JA; Clancy K; Rosenbaum JF; Fava M
Biol Psychiatry; 1996 Oct; 40(8):691-6. PubMed ID: 8894060
[TBL] [Abstract][Full Text] [Related]
32. Are there differences between women's and men's antidepressant responses?
Quitkin FM; Stewart JW; McGrath PJ; Taylor BP; Tisminetzky MS; Petkova E; Chen Y; Ma G; Klein DF
Am J Psychiatry; 2002 Nov; 159(11):1848-54. PubMed ID: 12411218
[TBL] [Abstract][Full Text] [Related]
33. Does lofepramine have fewer side effects than amitriptyline? Results of a comparative trial.
Pugh R; Bell J; Cooper AJ; Dunstan S; Greedharry D; Pomeroy J; Raptopoulos P; Rowsell C; Steinert J; Priest RG
J Affect Disord; 1982 Dec; 4(4):355-63. PubMed ID: 6219149
[TBL] [Abstract][Full Text] [Related]
34. Platelet 5-HT uptake sites, labelled with [3H] paroxetine, in controls and depressed patients before and after treatment with fluoxetine or lofepramine.
Lawrence KM; Katona CL; Abou-Saleh MT; Robertson MM; Nairac BL; Edwards DR; Lock T; Burns RA; Harrison DA; Horton RW
Psychopharmacology (Berl); 1994 Jun; 115(1-2):261-4. PubMed ID: 7862905
[TBL] [Abstract][Full Text] [Related]
35. Atypical depression, atypical temperament and a differential antidepressant response to fluoxetine and nortriptyline.
Joyce PR; Mulder RT; McKenzie JM; Luty SE; Cloninger CR
Depress Anxiety; 2004; 19(3):180-6. PubMed ID: 15129420
[TBL] [Abstract][Full Text] [Related]
36. Treatment-related adverse events and outcome in a clinical trial of fluoxetine for major depressive disorder.
Papakostas GI; Petersen T; Denninger JW; Montoya HD; Nierenberg AA; Alpert JE; Fava M
Ann Clin Psychiatry; 2003; 15(3-4):187-92. PubMed ID: 14971864
[TBL] [Abstract][Full Text] [Related]
37. Moclobemide versus fluoxetine in the treatment of major depressive disorder in adults.
Lapierre YD; Joffe R; McKenna K; Bland R; Kennedy S; Ingram P; Reesal R; Rickhi BG; Beauclair L; Chouinard G; Annable L
J Psychiatry Neurosci; 1997 Mar; 22(2):118-26. PubMed ID: 9074306
[TBL] [Abstract][Full Text] [Related]
38. Dichotic listening tests of functional brain asymmetry predict response to fluoxetine in depressed women and men.
Bruder GE; Stewart JW; McGrath PJ; Deliyannides D; Quitkin FM
Neuropsychopharmacology; 2004 Sep; 29(9):1752-61. PubMed ID: 15238992
[TBL] [Abstract][Full Text] [Related]
39. Fluoxetine in the treatment of depression in Asian (Chinese and Indian) patients in Singapore.
Tsoi WF; Tan CT; Kok LP
Singapore Med J; 1995 Aug; 36(4):397-9. PubMed ID: 8919155
[TBL] [Abstract][Full Text] [Related]
40. Fluoxetine treatment of depressed patients with comorbid anxiety disorders.
Sonawalla SB; Farabaugh A; Johnson MW; Morray M; Delgado ML; Pingol MG; Rosenbaum JF; Fava M
J Psychopharmacol; 2002 Sep; 16(3):215-9. PubMed ID: 12236627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
